SEMMA THERAPEUTICS Trademark

Trademark Overview

On Tuesday, January 27, 2015, a trademark application was filed for SEMMA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SEMMA THERAPEUTICS trademark a serial number of 86515333. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 20, 2024. This trademark is owned by Semma Therapeutics, Inc.. The SEMMA THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

pharmaceutical drug development services; cell-based therapy development services, namely, medical research in the field of diabetes and metabolic disease; laboratory research services relating to pharmaceuticals; conducting research and clinical trials for others relating to medical devices, cell-based therapies and pharmaceuticals in the field of diabetes and metabolic disease
semma therapeutics

General Information

Serial Number86515333
Word MarkSEMMA THERAPEUTICS
Filing DateTuesday, January 27, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 20, 2024
Registration Number5418559
Registration DateTuesday, March 6, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 7, 2015

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and Servicespharmaceutical drug development services; cell-based therapy development services, namely, medical research in the field of diabetes and metabolic disease; laboratory research services relating to pharmaceuticals; conducting research and clinical trials for others relating to medical devices, cell-based therapies and pharmaceuticals in the field of diabetes and metabolic disease

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 20, 2024
Primary Code042
First Use Anywhere DateSunday, May 15, 2016
First Use In Commerce DateSunday, May 15, 2016

Trademark Owner History

Party NameSemma Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameSemma Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameSemma Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Trademark Events

Event DateEvent Description
Friday, January 30, 2015NEW APPLICATION ENTERED
Thursday, February 5, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 1, 2015ASSIGNED TO EXAMINER
Friday, May 1, 2015NON-FINAL ACTION WRITTEN
Friday, May 1, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 1, 2015NON-FINAL ACTION E-MAILED
Wednesday, May 6, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 6, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 7, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 8, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 3, 2015ASSIGNED TO LIE
Wednesday, June 3, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 17, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 7, 2015PUBLISHED FOR OPPOSITION
Tuesday, July 7, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 1, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 18, 2016SOU TEAS EXTENSION RECEIVED
Thursday, February 18, 2016SOU EXTENSION 1 FILED
Thursday, February 18, 2016SOU EXTENSION 1 GRANTED
Saturday, February 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 31, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, August 31, 2016SOU EXTENSION 2 FILED
Monday, September 19, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 26, 2016SOU EXTENSION 2 GRANTED
Tuesday, September 27, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 28, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, February 28, 2017SOU EXTENSION 3 FILED
Tuesday, February 28, 2017SOU EXTENSION 3 GRANTED
Thursday, March 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 24, 2017TEAS STATEMENT OF USE RECEIVED
Monday, July 24, 2017SOU TEAS EXTENSION RECEIVED
Monday, July 24, 2017SOU EXTENSION 4 FILED
Monday, July 24, 2017USE AMENDMENT FILED
Friday, August 4, 2017SOU EXTENSION 4 GRANTED
Saturday, August 5, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 29, 2017STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 26, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 26, 2017NON-FINAL ACTION E-MAILED
Thursday, October 26, 2017SU - NON-FINAL ACTION - WRITTEN
Monday, January 29, 2018SU-EXAMINER'S AMENDMENT WRITTEN
Monday, January 29, 2018EXAMINER'S AMENDMENT ENTERED
Monday, January 29, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 29, 2018EXAMINERS AMENDMENT E-MAILED
Tuesday, January 30, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 31, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 6, 2018REGISTERED-PRINCIPAL REGISTER
Monday, March 6, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, September 20, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

therapeutics semma research services field pharmaceuticals metabolic disease medical relating diabetes cell